Tus kws kho mob
P10-16 New Drug-Related Prior Authorization Criteria for Gattex
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2016
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2981 - 2990 ntawm 4179
Tus kws kho mob
P16-16 Blue Cross Contracts with SecureCare to Manage the Chiropractic Network
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 22, 2016
Tus kws kho mob
P4-16 New Drug-Related Prior Authorization Criteria for Myalept
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 08, 2016
Tus kws kho mob
P33-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Northera
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2016
Tus kws kho mob
P11-16 New Drug-Related Prior Authorization Criteria: Idiopathic P ulmonary Fibrosis Prior Authorization with Quantity Limit Criteria: Esbriet ® and Ofev ®
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 08, 2016
Tus kws kho mob
P50-17 Provider Data Accuracy and Identified Lack of Claim Submissions
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P30-16 New Prior Authorization Requirement for Lyme Disease: Diagnostic Testing and Intravenous Antibiotic Therapy
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 07, 2016
Tus kws kho mob
P14-16 Addition of Lazanda ® to Existing Drug-Related Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 29, 2016
Tus kws kho mob
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 27, 2016
Tus kws kho mob
P24-16 Providers will see a change in our Prior Authorization Process for Government Products
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2016